US Broker Ratings

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Unearthing a 23% Upside Potential in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a compelling player in the biotechnology sector, is capturing the attention of investors with its robust pipeline of peptide therapeutics and..

Phreesia, Inc. (PHR) Stock Analysis: 14.81% Potential Upside Fuels Investor Interest

Phreesia, Inc. (PHR), a key player in the Health Information Services industry, is making waves in the healthcare sector with its innovative software and payment solutions...

Acadia Healthcare (ACHC) Stock Analysis: A 94.89% Potential Upside Beckons Investors

In the vast landscape of healthcare investments, Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents a compelling case for investor attention. With a market capitalization of $2.03..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Navigating a 17% Potential Upside Amidst Operational Challenges

Brookdale Senior Living Inc. (NYSE: BKD) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within medical care facilities. With its headquarters..

Surgery Partners, Inc. (SGRY) Stock Analysis: Uncovering a 34% Potential Upside in Healthcare Sector

Surgery Partners, Inc. (SGRY) stands as a noteworthy contender in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, this company..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 36.66% Potential Upside

ICU Medical, Inc. (ICUI), a key player in the healthcare sector, operates in the niche industry of medical instruments and supplies. With a market capitalization of..

National HealthCare Corporation (NHC) Stock Analysis: Strong Revenue Growth and Reliable Dividends for Healthcare Investors

National HealthCare Corporation (NYSE: NHC) presents a compelling case for investors interested in the healthcare sector. With a robust market capitalization of $1.62 billion, NHC operates..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Eyeing a 75% Upside with Strong Buy Ratings

Investors with a focus on biopharmaceutical innovation might find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) a compelling addition to their portfolios. Specializing in neuroscience-focused therapeutics, Xenon is..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a Potential 71.65% Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a promising player in the biotechnology sector, has been capturing investor attention with its innovative approach to eye care treatment. Headquartered..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unpacking a 142% Potential Upside

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering entity in the biotechnology sector, is drawing significant attention from investors due to its impressive potential upside of 142.52%,..

Mirum Pharmaceuticals (MIRM) Stock Analysis: Potential Upside of 45.8% Draws Investor Attention

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has been capturing investor interest with its robust growth prospects and strong analyst ratings. As a player in the biotechnology sector,..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: A 16.62% Upside Potential in CNS Drug Market

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a prominent player in the biopharmaceutical sector, is poised for growth with an enticing potential upside of 16.62%. As the company..

Guardian Pharmacy Services, Inc. (GRDN): Investor Outlook Highlights a Promising 34.45% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) is capturing the attention of investors with its impressive growth trajectory and promising market opportunities. As a key player in..

AtriCure, Inc. (ATRC) Stock Analysis: Unveiling a 45.96% Potential Upside in the Surgical Devices Market

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with its potential..

BGM Group Ltd. (BGM): Investor Outlook on Healthcare Innovator with Mixed Performance Metrics

BGM Group Ltd. (BGM), a prominent player in China’s healthcare sector, is a fascinating entity for investors interested in unique pharmaceutical and agricultural solutions. With a..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech Gem with 74.81% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a promising entity in the biotechnology sector, is capturing investor attention with a compelling potential upside of 74.81%. Specializing in the development..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Potential 163.82% Upside

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a UK-based biotechnology powerhouse, is capturing investor attention with its impressive growth potential. With a market capitalization of $1.6 billion, the..

Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech with 97.90% Revenue Growth

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company from China, is making waves in the healthcare sector, particularly within the biotechnology industry. The company’s focus..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Analyzing a 45.78% Potential Upside in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) has been capturing investor attention with its robust potential upside and promising pipeline in the biotechnology sector. This Cambridge, Massachusetts-based..

Addus HomeCare Corporation (ADUS) Stock Analysis: Healthcare’s Hidden Gem with 17% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS), a key player in the healthcare sector’s medical care facilities industry, is garnering significant attention from investors due to its promising..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds